A Highly Accurate and Linear Clauss Fibrinogen Assay Provides Increased Clinical Value for Patient Reporting throughout the 30 – 1000 mg/dL Medical Decision-Making Range.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 3935-3935
Author(s):  
Janet Callahan ◽  
Nathalie Laurant ◽  
Sam Arcidiacono ◽  
Janos Polgar ◽  
Doyle Mary ◽  
...  

Abstract The availability of accurate and precise Fibrinogen concentration measurements throughout low, normal and elevated ranges are of significant utility in clinical practice. The assessment of elevated fibrinogen levels is valuable as a known marker of coronary heart disease, cerebrovascular disease, cancer, diabetes, hypertension, acute phase reactions, pregnancy, etc. Likewise, the decreased fibrinogen levels associated with liver disease, DIC, thrombolytic therapy, miscarriage, poor wound healing and intracranial hemorrhage support the premise that accurate quantification of very low levels of fibrinogen is needed. The Hemosil TM Fibrinogen-C XC Clauss Fibrinogen (FibC) assay measurement range for Instrumentation Laboratory (IL) ACL TOP family (ACL TOP/CTS) analyzers has been expanded to 30–1000 mg/dL. This assay has the capability of accurately measuring plasma fibrinogen in three mode segments: Near Normal for the 100–500mg/dL range, High Fib for samples 500 to 1000mg/dL and Low Fib for samples less than 100mg/dL. The accuracy of the expanded Fibrinogen assay was assured by calibration with the 2nd International Standard for Fibrinogen calibrator, plasma 98/612 and verification with the SCC/ISTH Secondary Coagulation Standard Lot # 3 as well as a 100 donor normal pool. Precision is consistent across the entire range. Normal, low and high samples demonstrated Total CVs of < 7%. The linearity of values across the expanded Fib C measurement range was established using a statistical evaluation based on CLSI EP6-A: Evaluation of the Linearity of Quantitative Measurement Procedures. Overlapping linearity of the 3 mode segments was demonstrated for Low Fib from 30–150 mg/dL, for Fib C from 85–500 mg/dL, for High Fib from 200 –1000 mg/dL as well as for the overall range of 30–1000 mg/dL. As noted, recovered values from Low Fib to Fib C and from Fib C to High Fib overlap when the tests are evaluated individually, but in practice, this Fib C assay will reflex seamlessly to the appropriate low or high test range. Deviation from Linearity, a statistical measure of goodness of fit, was low, less than 7% for 9 equidistant points between 30 and 1100 mg/dL. Linearity and accuracy were further confirmed in an extensive and statistically rigorous CLSI EP9 method comparison study of 200 samples representing a wide variety of clinical disorders Additional studies investigated interferences and other sample specific conditions. Measurements using reflexive modes to extend the Fibrinogen measurable range deliver timely, precise and accurate information to the practicing clinician over the wide diagnostic range of 30–1000 mg/dL.

2021 ◽  
Vol 9 (1) ◽  
pp. 8
Author(s):  
Evmorfia P. Bataka ◽  
Georgios Miliokas ◽  
Nikolaos Katsoulas ◽  
Christos T. Nakas

Open-source devices are widespread and have been available to everyone over the past decade. The low cost of such devices boosts the creation of instruments for various applications such as smart farming, environmental monitoring, animal behavior monitoring, human health monitoring, etc. This research aims to use statistical methods to assess agreement and similarity in order to compare an open-source weather station that was constructed and programmed from scratch with an industrial weather station. The experiment took place in the experimental Greenhouses of the University of Thessaly, Velestino, Greece, for 7 consecutive days. The topology of the experiment consisted of 30 open-source weather stations and three industrials, creating three clusters with a ratio of 10 open-source to 1 industrial. The results revealed low to high agreement across the measurement range, with high variability, possibly due to factors that were not considered in the statistical model.


2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
T Besbes ◽  
S Mleyhi ◽  
J Sahli ◽  
M Messai ◽  
J Ziadi ◽  
...  

Abstract Background Early prediction of patients at highest risk of a poor outcome after cardiovascular surgery, including death can aid medical decision making, and adapt health care management in order to improve prognosis. In this context, we conducted this study to validate the CASUS severity score after cardiac surgery in the Tunisian population. Methods This is a retrospective cohort study conducted among patients who underwent cardiac surgery under extracorporeal circulation during the year 2018 at the Cardiovascular Surgery Department of La Rabta University Hospital in Tunisia. Data were collected from the patients hospitalization records. The discrimination of the score was assessed using the ROC curve and the calibration using the Hosmer-Lemeshow goodness of fit test and then by constructing the calibration curve. Overall correct classification was also obtained. Results In our study, the observed mortality rate was 10.52% among the 95 included patients. The discriminating power of the CASUS score was estimated by the area under the ROC curve (AUC), this scoring system had a good discrimination with AUC greater than 0.9 from postoperative Day 0 to Day 5.From postoperative day 0 to day 5, the Hosmer-Lemeshow's test gave a value of chi square test statistic ranging from 1.474 to 8.42 and a value of level of significance ranging from 0.39 to 0.99 indicating a good calibration. The overall correct classification rate from postoperative day 0 to day 5 ranged from 84.4% to 92.4%. Conclusions Despite the differences in the profile of the risk factors between the Tunisian population and the population constituting the database used to develop the CASUS score, we can say that this risk model presents acceptable performances in our population, attested by adequate discrimination and calibration. Prospective and especially multicentre studies on larger samples are needed before definitively conclude on the performance of this model in our country. Key messages The casus score seems to be valid to predict mortality among patients undergoing cardiac surgery. Multicenter study on larger sample is needed to derive and validate models able to predict in-hospitals mortality.


Sadhana ◽  
2015 ◽  
Vol 40 (5) ◽  
pp. 1457-1472 ◽  
Author(s):  
T V DIXIT ◽  
ANAMIKA YADAV ◽  
S GUPTA

2017 ◽  
Vol 88 (5) ◽  
pp. 464-467
Author(s):  
Carolyn R. Chew ◽  
Tracey Lam ◽  
Steven T. F. Chan ◽  
Laura Chin-Lenn

2016 ◽  
Vol 20 (2) ◽  
pp. 63-66 ◽  
Author(s):  
Aileen Azari-Yam ◽  
Samira Dabbagh Bagheri ◽  
Javad Tavakkoly–Bazzaz ◽  
Ameneh Bandehi Sarhaddi ◽  
Leili Rejali ◽  
...  

2018 ◽  
Vol 56 (2) ◽  
pp. 312-322 ◽  
Author(s):  
Joannes F.M. Jacobs ◽  
Corrie M. de Kat Angelino ◽  
Huberdina M.L.M. Brouwers ◽  
Sandra A. Croockewit ◽  
Irma Joosten ◽  
...  

Abstract Background: Serum free light chain (sFLC) measurements are increasingly important in the context of screening for monoclonal gammopathies, prognostic stratification, and monitoring of therapy responses. At the same time, analytical limitations have been reported with the currently available nephelometric and turbidimetric sFLC assays. We have evaluated a new quantitative sFLC ELISA for its suitability in routine clinical use. Methods: Reference ranges of the Sebia FLC assay were calculated from 208 controls. Assay interference, reproducibility, lot-to-lot variability, and linearity were assessed. Method comparison to the Freelite assay (Binding Site) was conducted by retrospective analysis of 501 patient sera. Results: Reference ranges of the Sebia κ/λFLC-ratio were 0.37–1.44. We observed good sensitivity (1.5 mg/L) and linearity in both polyclonal and monoclonal sFLC samples and never experienced antigen excess. Sebia FLC reproducibility varied between 6.7% and 8.1% with good lot-to-lot consistency. Method comparison with Freelite showed the following correlations: κFLC R=0.94, λFLC R=0.92 and κ/λFLC-ratio R=0.96. The clinical concordance of the κ/λFLC-ratio of both methods was 94%. Significant quantitative differences were observed between both methods, mainly in sera with high FLC concentrations. The Sebia monoclonal FLC concentrations were coherent with those obtained by serum protein electrophoresis (SPE). Freelite monoclonal FLC concentrations were consistently higher, with a mean 12-fold overestimation compared to SPE. Conclusions: The Sebia FLC assay provides a novel platform for sensitive and accurate sFLC measurements. The Sebia FLC showed good clinical concordance with Freelite. Further studies are warranted to confirm the clinical value of this assay.


2019 ◽  
Vol 119 (11) ◽  
pp. 1767-1772 ◽  
Author(s):  
Carla Valsecchi ◽  
Maribel Mirabet ◽  
Ilaria Mancini ◽  
Marina Biganzoli ◽  
Lucia Schiavone ◽  
...  

AbstractThrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy (TMA) characterized by the severe deficiency of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) activity (< 10%). Rapid ADAMTS13 testing is crucial for an early diagnosis and optimal management of acute TTP. We evaluated the performance of the HemosIL AcuStar ADAMTS13 activity assay (Instrumentation Laboratory, Bedford, Massachusetts, United States), a fully automated chemiluminescent immunoassay with an analytical time of 33 minutes. A method comparison study was performed on 176 samples from 49 healthy donors and 127 TMA patients (109 TTP, 7 atypical hemolytic uremic syndrome, 11 other TMAs), comparing this new assay with an in-house FRETS-VWF73 assay and a commercial enzyme-linked immunosorbent assay (ELISA) (TECHNOZYM ADAMTS-13 Activity, Technoclone GmbH, Vienna, Austria). Agreement between methods was assessed with focus on ADAMTS13 activity less than 10%, the medical decision level relevant for TTP diagnosis. The HemosIL AcuStar ADAMTS13 Activity showed good correlation with both the FRETS-VWF73 (r = 0.96) and ELISA (r = 0.96) methods. Slope of the Passing–Bablok regression was 1.05 for FRETS-VWF73 and 1.02 for ELISA, and absolute bias at the medical decision level was +0.1 and +0.3%, respectively. The study also revealed high agreement with FRETS-VWF73 (kappa 0.97) and ELISA (kappa 0.98) methods in classifying TTP patients with a severe deficiency of ADAMTS13 activity. Because of its short turnaround time and full automation, the HemosIL AcuStar ADAMTS13 activity assay might become the assay of choice to rapidly test ADAMTS13 activity in plasma and thus establish the diagnosis of acute TTP in emergency settings.


1990 ◽  
Vol 36 (8) ◽  
pp. 1444-1449 ◽  
Author(s):  
R H Christenson ◽  
P Clemmensen ◽  
E M Ohman ◽  
J Toffaletti ◽  
L M Silverman ◽  
...  

Abstract We compared relative increases in creatine kinase (EC 2.7.3.2) MB isoenzyme (CK-MB) after reperfusion in myocardial infarction for four popular methods: electrophoresis, immunoinhibition, the "Magic Lite" (Ciba-Corning) system, and the Stratus (Dade). In a method comparison study, we confirmed that all four methods correlated (r greater than 0.95). Electrophoresis demonstrated the greatest scatter about the regression line, immunoinhibition the least. For CK-MB quantities near each method's "positive cutoff" indicating myocardial infarction, results by all methods agreed in 95% of samples. To characterize relative increases in CK-MB, we computer-fitted data obtained from each method for serial specimens collected from six acute myocardial infarction patients during myocardial reperfusion. Although for each individual patient the four methods appeared to exhibit parallelism, the methods differed significantly in terms describing their appearance rate, peak-time & fall-off, and time-to-peak activity. Consistent with these data, we found that the relative CK-MB increases at various times after reperfusion, compared with baseline concentrations, are method-dependent. Therefore, when using CK-MB for indicating coronary patency, one must develop specific limits for each method utilized.


Sign in / Sign up

Export Citation Format

Share Document